Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | TEVA | BBIO | RDY | SUPN |
| Company | Cymabay Therapeutics | Teva Pharmaceutical Industries ADR | Bridgebio Pharma Inc | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 32.49 | 30.29 | 75.36 | 14.02 | 48.87 |
| High | 32.50 | 30.39 | 75.92 | 14.06 | 49.78 |
| Low | 32.48 | 29.88 | 73.48 | 13.94 | 48.63 |
| Latest | 32.48 | 30.14 | 74.26 | 13.97 | 49.33 |
| Change | +0.01 | +0.08 | +0.24 | +0.04 | +0.58 |
| % Change | +0.03% | +0.27% | +0.32% | +0.29% | +1.19% |
| Volume | 8,356,200 | 4,101,770 | 746,266 | 1,002,545 | 389,946 |
| 20-Day Average Volume | 3,390,805 | 9,972,825 | 1,992,931 | 1,111,385 | 634,827 |
| Previous Close | 32.47 | 30.06 | 74.02 | 13.93 | 48.75 |
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 27.84 | 72.52 | 13.97 | 46.19 |
| 20-Day Raw Stochastic | 94.12% | 93.47% | 82.89% | 56.14% | 96.31% |
| 20-Day Relative Strength | 78.00 | 77.29 | 63.50 | 49.18 | 58.42 |
| Weighted Alpha | +247.60 | +71.16 | +189.94 | -7.41 | +48.15 |
| Today's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Sell | 72% Buy |
| Previous Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Sell | 64% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 56% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | -0.53% since 12/11/25 | +0.51% since 12/11/25 | -0.96% since 12/11/25 | +6.58% since 12/11/25 |
| Low | 32.44 on 03/15/24 | 29.56 on 12/12/25 | 72.65 on 12/12/25 | 13.90 on 12/16/25 | 46.36 on 12/12/25 |
| High | 32.50 on 03/21/24 | 30.44 on 12/15/25 | 76.51 on 12/16/25 | 14.16 on 12/12/25 | 49.78 on 12/18/25 |
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | +20.85% since 11/18/25 | +13.49% since 11/18/25 | -0.46% since 11/18/25 | +10.40% since 11/18/25 |
| Low | 32.15 on 02/22/24 | 24.01 on 11/21/25 | 64.41 on 11/21/25 | 13.64 on 11/24/25 | 44.09 on 12/02/25 |
| High | 32.50 on 03/21/24 | 30.44 on 12/15/25 | 76.51 on 12/16/25 | 14.20 on 12/05/25 | 49.78 on 12/18/25 |
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | +62.71% since 09/18/25 | +39.58% since 09/18/25 | -5.90% since 09/18/25 | +7.46% since 09/18/25 |
| Low | 22.11 on 01/26/24 | 18.21 on 09/25/25 | 48.78 on 09/25/25 | 13.14 on 10/29/25 | 43.11 on 11/05/25 |
| High | 32.50 on 03/21/24 | 30.44 on 12/15/25 | 76.51 on 12/16/25 | 14.97 on 09/19/25 | 57.65 on 10/30/25 |
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | +75.97% since 06/18/25 | +86.10% since 06/18/25 | -8.13% since 06/18/25 | +50.39% since 06/18/25 |
| Low | 12.32 on 10/13/23 | 14.99 on 08/01/25 | 40.19 on 06/20/25 | 13.14 on 10/29/25 | 30.83 on 06/25/25 |
| High | 32.50 on 03/21/24 | 30.44 on 12/15/25 | 76.51 on 12/16/25 | 15.71 on 06/25/25 | 57.65 on 10/30/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 34,477,616 | 14,264,319 | 11,630,686 | 2,795,276 |
| Shares Outstanding, K | 114,724 | 1,146,960 | 192,709 | 834,938 | 57,339 |
| Annual Sales | 31,070,000 | 16,544,000,000 | 221,900,000 | 3,811,000,000 | 661,820,000 |
| Annual Net Income | -105,370,000 | -1,639,000,000 | -535,760,000 | 663,000,000 | 73,870,000 |
| Last Quarter Sales | 60,000 | 4,480,000,000 | 120,700,000 | 1,012,590,000 | 192,100,000 |
| Last Quarter Net Income | -41,900,000 | 433,000,000 | -182,740,000 | 165,280,000 | -45,120,000 |
| 60-Month Beta | 0.32 | 0.67 | 1.26 | 0.39 | 0.71 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.78 on 11/05/25 | -0.95 on 10/29/25 | 0.19 on 10/24/25 | 1.01 on 11/04/25 |
| Latest Earnings Date | 05/20/24 | 01/28/26 | 02/19/26 | 01/22/26 | 02/24/26 |
| Most Recent Dividend | N/A | 0.072 on 11/27/17 | N/A | 0.071 on 07/25/25 | N/A |
| Next Ex-Dividends Date | N/A | 11/27/17 | N/A | 07/25/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 11.67 | 0.00 | 17.17 | 22.69 |